• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Profound Medical Corp. - common stock (NQ:PROF)

    7.870 +0.540 (+7.37%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 255,161
    Open 7.240
    Bid (Size) 7.860 (100)
    Ask (Size) 7.950 (200)
    Prev. Close 7.330
    Today's Range 7.205 - 7.970
    52wk Range 3.760 - 7.990
    Shares Outstanding 20,208,948
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    InvestorNewsBreaks – Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) Closes $36 Million Registered Direct Offering
    Via Investor Brand Network
    News headline image
    Profound Medical Corp. Announces Closing of Private Placement
    From Profound Medical Corp.
    Via GlobeNewswire

    Performance

    YTD
    -0.4%
    -0.4%
    1 Month
    +22.6%
    +22.6%
    3 Month
    +60.9%
    +60.9%
    6 Month
    +29.0%
    +29.0%
    1 Year
    +11.6%
    +11.6%

    More News

    Read More
    News headline image
    Profound Medical Corp. Announces Upsize of Private Placement
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For November 13, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 14, 2025 ↗
    Via Benzinga
    News headline image
    Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Reports Strong Third Quarter 2025 Financial Results
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data Presentation
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical to Launch AI-Powered BPH Module, Present New TULSA-PRO® Clinical Data, at RSNA and SUO Meetings
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical to Participate in the Stifel 2025 Healthcare Conference
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Congratulates the Busch Center for Achieving 500th TULSA Procedure Milestone
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical to Participate in Lake Street’s 9th Annual Best Ideas Growth Conference
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Posts Wider Loss in Q2 ↗
    Via The Motley Fool
    News headline image
    Profound Medical Announces Second Quarter 2025 Financial Results
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®
    From Profound Medical Corp.
    Via GlobeNewswire
    News headline image
    Profound Medical Annual General and Special Meeting of Shareholders Voting Results
    From Profound Medical Corp.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Profound Medical Corp. - common stock publicly traded?
    Yes, Profound Medical Corp. - common stock is publicly traded.
    What exchange does Profound Medical Corp. - common stock trade on?
    Profound Medical Corp. - common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Profound Medical Corp. - common stock?
    The ticker symbol for Profound Medical Corp. - common stock is PROF on the Nasdaq Stock Market
    What is the current price of Profound Medical Corp. - common stock?
    The current price of Profound Medical Corp. - common stock is 7.870
    When was Profound Medical Corp. - common stock last traded?
    The last trade of Profound Medical Corp. - common stock was at 12/31/25 04:00 PM ET
    What is the market capitalization of Profound Medical Corp. - common stock?
    The market capitalization of Profound Medical Corp. - common stock is 159.04M
    How many shares of Profound Medical Corp. - common stock are outstanding?
    Profound Medical Corp. - common stock has 159M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.